With 32% ownership, Nautilus Biotechnology, Inc. (NASDAQ:NAUT) insiders have a lot riding on the company's future [Yahoo! Finance]
Nautilus Biotechnology, Inc. (NAUT)
Company Research
Source: Yahoo! Finance
A total of 4 investors have a majority stake in the company with 54% ownership 20% of Nautilus Biotechnology is held by Institutions A look at the shareholders of Nautilus Biotechnology, Inc. ( NASDAQ:NAUT ) can tell us which group is most powerful. We can see that individual insiders own the lion's share in the company with 32% ownership. Put another way, the group faces the maximum upside potential (or downside risk). So it follows, every decision made by insiders of Nautilus Biotechnology regarding the company's future would be crucial to them. Let's take a closer look to see what the different types of shareholders can tell us about Nautilus Biotechnology. Check out our latest analysis for Nautilus Biotechnology What Does The Institutional Ownership Tell Us About Nautilus Biotechnology? Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the
Show less
Read more
Impact Snapshot
Event Time:
NAUT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NAUT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NAUT alerts
High impacting Nautilus Biotechnology, Inc. news events
Weekly update
A roundup of the hottest topics
NAUT
News
- Nautilus Biotechnology, Inc. (NASDAQ: NAUT) is now covered by analysts at Guggenheim. They set a "buy" rating and a $6.00 price target on the stock.MarketBeat
- Nautilus Biotechnology, Inc. (NASDAQ: NAUT) is now covered by analysts at Jefferies Financial Group Inc.. They set a "hold" rating and a $3.00 price target on the stock.MarketBeat
- Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceGlobeNewswire
- Nautilus Biotechnology (NAUT) Upgraded to Buy: Here's What You Should Know [Yahoo! Finance]Yahoo! Finance
- We're Hopeful That Nautilus Biotechnology (NASDAQ:NAUT) Will Use Its Cash Wisely [Yahoo! Finance]Yahoo! Finance
NAUT
Earnings
- 4/30/24 - Beat
NAUT
Sec Filings
- 6/17/24 - Form 4
- 6/17/24 - Form 4
- 6/17/24 - Form 4
- NAUT's page on the SEC website